In general, state Medicaid programs must cover all FDA-approved drugs. But in a handful of cases, including weight loss medications, states get to decide for themselves. Connecticut’s policy ...

The high costs of these drugs have led some insurers to roll back coverage. Advocates say cutting off access to save money is short-sighted, failing ... weight loss medications, states get to decide ...

The Department of Social Services remains committed to exploring policy solutions that maximize health outcomes while maintaining fiscal sustainability.

WSHU sits down with CT Mirror’s Katy Golvala to discuss her story about the debate over Medicaid coverage of weight loss ...

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

GLP-1’s, drugs like Ozempic and Wegovy, cost Connecticut ... Medicaid keep covering them? WSHU: Hi, Katy. You talk about Sarah Makowicki as an example of what's going on with weight loss drugs ...

Patients on Medicare and Medicaid are not eligible ... a demographic that largely lacks insurance coverage for weight loss drugs like Wegovy. To get Novo Nordisk’s drug, these patients must ...

Many Marylanders struggle with obesity but cannot get access to weight loss medications because insurance will not pay for them. A proposed bill would make the drugs available to Medicaid patients ...